COMMERCIAL DETAILS Sample Clauses

COMMERCIAL DETAILS. Tax exemptions. By statute the City of Fort Xxxxxxx is exempt from state and local taxes. Our Exemption Number is 11. NONWAIVER. Page 2 of 2 98-04502. Federal Excise Tax Exemption Certificate of Registry 00-0000000 is registered with the Collector of Internal Revenue, Denver, Colorado (Ref. Colorado Revised Statutes 1973, Chapter 39-26, 114 (a). Goods Rejected. GOODS REJECTED due to failure to meet specifications, either when shipped or due to defects of damage in transit, may be returned to you for credit and are not to be replaced except upon receipt of written instructions from the City of Fort Xxxxxxx.
AutoNDA by SimpleDocs
COMMERCIAL DETAILS. 1. Our Details Name and ABN Advanced Human Imaging Limited ABN 85 602 111 115 (we, us, our) Office Address Xxxx 0, 00-00 Xxxxx Xxxxx Xxxxxxxxx, South Perth WA 6151 Australia 2. Client Details Name and Business / Company Number Bearn Inc (you, your) Xxxxxx Xxxxxxx 000 Xxx Xxxxxx, Xxx Xxxxx XX, 00000
COMMERCIAL DETAILS. Approved Currencies: Sterling Base Funding Limit: (Until replaced by specific Funding Limits) 10% of Outstanding Notified Debts Concentration Percentage: 60% of all Outstanding Notified Debts Debt Turn Target: 65 days Funding Period: UK Debts: 90 days from end of month of invoice Law: English law governs this Agreement Minimum Period: 12 months starting on the Commencement Date Monthly Returns Due Date: 15th day of each month Notice Period: 6 months Prepayment Percentage: UK Debts: 50% Prepayment Review Level: £3,000,000
COMMERCIAL DETAILS. 1. Our Details Name and ABN Advanced Human Imaging Limited ABN 85 602 111 115 (we, us, our) Office Address Xxxx 0, 00-00 Xxxxx Xxxxx Xxxxxxxxx, South Perth WA 6151 Australia 2. Client Details Name and Business / Company Number FITTRACK INCORPORATED, Corporation Number 1117132-1 ; FitTrack LLC, a Delaware company 7252549; FitTrack France SAS, a French company; and FitTrack UK Ltd., a United Kingdom company 12971836 (jointly and each severally, you, your) Xxxxxx Xxxxxxx 000 Xxxxx Xx Xxxx, Xxxxxxx, Xxxxxxx X0X 0X0
COMMERCIAL DETAILS. A. HIRER DETAILS Hirer name & address ("the Hirer") Name of Hirer: Address: Contact person: Telephone: Email:
COMMERCIAL DETAILS. In this Agreement, the following words shall have the following meanings, unless the context otherwise requires: Completion Date [INSERT] Escrow Agent [INSERT] University Representative [INSERT THE NAME OF THE UNIVERSITY’S AUTHORISED REPRESENTATIVE] and any other person that University Representative nominates by giving notice in writing to the 1 Supplier Liquidated Damages (where applicable) [INSERT AMOUNT] Liquidated Damages Period (where applicable) Initial Term [INSERT] Site(s) [INSERT] Start Date [INSERT THE DATE THAT THE SYSTEM/SERVICES WILL START TO BE PROVIDED. ALTERNATIVELY IF THERE IS NO START DATE DETERMINED AT THE DATE OF SIGNATURE INSERT “THE DATE ON WHICH THE SUPPLIER COMMENCES DELIVERY OF THE SYSTEM OR PROVISION OF THE SERVICES, SUCH DATE TO BE AGREED BETWEEN THE PARTIES” OR IF THE SYSTEM/SERVICES PROVISION WILL START ON THE DATE OF SIGNATURE INSERT “THE EFFECTIVE DATE”]

Related to COMMERCIAL DETAILS

  • Commercial Supply Celgene shall Manufacture and supply all Commercial Supplies.

  • Legal Details All legal details and proceedings in connection with the transactions contemplated by this Agreement and the other Loan Documents shall be in form and substance satisfactory to the Agent and counsel for the Agent, and the Agent shall have received all such other counterpart originals or certified or other copies of such documents and proceedings in connection with such transactions, in form and substance satisfactory to the Agent and said counsel, as the Agent or said counsel may reasonably request.

  • Contact details (a) Except as provided below, the contact details of each Party for all communications in connection with the Finance Documents are those notified by that Party for this purpose to the Facility Agent on or before the date it becomes a Party.

  • Account Details (a) Account for payments to Counterparty: To be provided. Account for delivery of Shares to Counterparty: To be provided.

  • Commercial Diligence Upon execution of this Agreement, Licensee shall diligently proceed with Commercially Diligent Efforts to develop, manufacture, practice, sell and use the Licensed Products in order to make them readily available to the general public as soon as possible on commercially reasonable terms. Licensee shall continue active, diligent Commercially Diligent Efforts for one or more Licensed Product(s) throughout the term of this Agreement (“Actively Commercializing”). In addition, Licensee shall perform at least the following obligations as part of its due diligence activities hereunder:

  • REGULATORY ADMINISTRATION SERVICES BNY Mellon shall provide the following regulatory administration services for each Fund and Series:  Assist the Fund in responding to SEC examination requests by providing requested documents in the possession of BNY Mellon that are on the SEC examination request list and by making employees responsible for providing services available to regulatory authorities having jurisdiction over the performance of such services as may be required or reasonably requested by such regulatory authorities;  Assist with and/or coordinate such other filings, notices and regulatory matters and other due diligence requests or requests for proposal on such terms and conditions as BNY Mellon and the applicable Fund on behalf of itself and its Series may mutually agree upon in writing from time to time; and

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Account Details and Settlement Information Payments to Party A: Citibank, New York ABA No.: 021 000 089 Account No.: 4072-4601 Account Name: Morgan Stanley Capital Services Inc. Payments to Party B: Deutsche Bank ABA No.: 021001033 Account No: 01419663 Acct Name: XXXXX Xxnds Control - Stars West Ref: Morgan Stanley ABS Capital I Inc. Trust 2006-HE5

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

Time is Money Join Law Insider Premium to draft better contracts faster.